It is important to identify cases of latent tuberculosis infection (LTBI) who are at risk for tuberculosis (TB) reactivation. We aimed to evaluate the performance of interferon (IFN)-gamma-inducible protein 10 (IP-10) as a marker to detect LTBI in patients with inflammatory rheumatic diseases (IRD). This study comprised 76 consecutive subjects with IRD. Patients with a history of TB or having active TB were excluded. In all patients, IP-10 level was measured and tuberculin skin test (TST) and QuantiFERON-TB Gold In-Tube test (QFT-GIT) were performed. Seventy patients with complete test results were analyzed. Twenty-one (30%) QFT-GIT-positive patients were defined as having LTBI. IP-10 yielded 2197 pg/mL cut-off point. At this cut-off point, IP-10 showed 89% specificity with a sensitivity of 91% (AUC: 0.950, 95% CI 0.906–0.994). TST, QFT-GIT, and IP-10 were positive in 77.1%, 30%, and 44.3% of the patients, respectively. Concordance among the results of TST, QFT-GIT, and IP-10 tests was evaluated. Agreement was poor between IP-10 and TST (58.6%, κ = 0.19), whereas it was good between QFT-GIT and IP-10 (84.3%, κ = 0.65). The results of the present study demonstrated that sensitivity and specificity of released IP-10 were as high as those of QFT-GIT in indicating LTBI in IRD patient group.

This study aimed to investigate the validity and reliability of the 2-Minute Step Test (2MST) in patients with lumbar spinal stenosis (LSS). This cross-sectional study involved 55 volunteers, aged 18-80, diagnosed with lumbar spinal stenosis. The participants were assessed using the 2MST, the 2-Minute Walk Test (2MWT), the 6-Minute Walk Test (6MWT), the Visual Analogue Scale (VAS), and the Oswestry Disability Index (ODI). To evaluate the reliability of the 2MST, test-retest reliability was determined by administering the 2MST again after a 7-day interval. The reliability analysis included the intraclass correlation coefficient (ICC) with a 95% confidence interval (CI), standard error of measurement (SEM), and minimum detectable change at the 95% confidence level (MDC₉₅). For concurrent validity, the correlations of the 2MST with the 2MWT, 6MWT, and ODI were assessed. The 2MST exhibited excellent test-retest reliability (ICC = 0.94, SEM = 5.56, MDC₉₅=15.41) in LSS patients. Additionally, the 2MST showed significant correlations with the 2MWT (r = 0.842, p < 0.001), 6MWT (r = 0.819, p < 0.001), and ODI score (r = -0.722, p < 0.001). This study demonstrated that the 2MST is a valid and reliable tool for assessing exercise capacity in individuals with LSS. NCT06060821.